Prakash Chaudhari

Dr. Prakash Chaudhari

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2025 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
PCPrakash Chaudhari
Prakash Chaudhari
CDChhanda C. Danta
Chhanda C. Danta
ANAdel Nefzi
Adel Nefzi
The 1,3-thiazole scaffold represents a privileged heterocyclic framework present in a broad spectrum of biologically active molecules and associated with a wide range of pharmacological effects.

22 November 2024 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
MTMukund Tantak
Mukund Tantak
Ramanjaneyulu RayalaRamanjaneyulu Rayala
Ramanjaneyulu Rayala
PCPrakash Chaudhari
Prakash Chaudhari
CDCHHANDA CHARAN DANTA
CHHANDA CHARAN DANTA
ANAdel Nefzi
Adel Nefzi
Small-molecule probes are powerful tools for studying biological systems and can serve as lead compounds for developing new therapeutics. Especially, nitrogen heterocycles are of considerable importance in the pharmaceutical field. These compounds are found in numerous bioactive structures. Their synthesis often requires several steps or the use of functionalized starting materials. This review describes the use of vicinal diamines generated from modified short peptides to access substituted diaza- and triazacyclic compounds. Small-molecule diaza- and triazacyclic compounds with different substitution patterns and embedded in various molecular frameworks constitute important structure classes in the search for bioactivity. The compounds are designed to follow known drug likeness rules, including “Lipinski’s Rule of Five”. The screening of diazacyclic and traizacyclic libraries has shown the utility of these classes of compounds for the de novo identification of highly active compounds, including antimalarials, antimicrobial compounds, antifibrotic compounds, potent analgesics, and antitumor agents. Examples of the synthesis of diazacyclic and triazacyclic small-molecule libraries from vicinal chiral polyamines generated from modified short peptides and their application for the identification of highly active compounds are described.

Verified
Journal Article
Open access
PDF file
Ramanjaneyulu RayalaRamanjaneyulu Rayala
Ramanjaneyulu Rayala
PCPrakash Chaudhari
Prakash Chaudhari
ABAshley Bunnell
Ashley Bunnell
BRBracken Roberts
Bracken Roberts
DCDebopam Chakrabarti
Debopam Chakrabarti
ANAdel Nefzi
Adel Nefzi
Thiazole and piperazine are two important heterocyclic rings that play a prominent role in nature and have a broad range of applications in agricultural and medicinal chemistry. Herein, we report the parallel synthesis of a library of diverse piperazine-tethered thiazole compounds. The reaction of piperazine with newly generated 4-chloromethyl-2-amino thiazoles led to the desired piperazine thiazole compounds with high purities and good overall yields. Using a variety of commercially available carboxylic acids, the parallel synthesis of a variety of disubstituted 4-(piperazin-1-ylmethyl)thiazol-2-amine derivatives is described. the screening of the compounds led to the identification of antiplasmodial compounds that exhibited interesting antimalarial activity, primarily against the Plasmodium falciparum chloroquine-resistant Dd2 strain. The hit compound 2291-61 demonstrated an antiplasmodial EC50 of 102 nM in the chloroquine-resistant Dd2 strain and a selectivity of over 140.

Verified
Journal Article
Open access
PDF file
PCPrakash Chaudhari
Prakash Chaudhari
ABAshley Bunnell
Ashley Bunnell
Manivannan YegambaramManivannan Yegambaram
Manivannan Yegambaram
CDColette Dooley
Colette Dooley
ANAdel Nefzi
Adel Nefzi
Diaza-peptidomimetics are constrained compounds that mimic the biological efficacy of peptides while offering increased stability. We have previously reported the synthesis of bis-cyclic guanidine heterocyclic peptidomimetics as opioid ligands with mixed μ-, κ- and δ-opioid receptor interactions and their potential activity as novel analgesics. Using the same approach, we report here the synthesis of sulfonated and piperazine-tethered bis-cyclic guanidines and their in vitro screening results from radioligand competition binding assays at the μ- (MOR), δ- (DOR), and κ- (KOR) opioid receptors.